We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Featured Products View All

 
 

Product News View All

Phase 1 Clinical Trial of COVID-19 Vaccine UB-612 Initiates in Taiwan
Product News

The first volunteers have been safely dosed in COVAXX's Phase 1, open-label, dose-escalation study of the UB-612 vaccine candidate for COVID-19 in Taiwan.

READ MORE

New Collaboration Explores Efficacy of Gene Delivery Vector Tech in Diabetes and Multiple Sclerosis
Product News

Amarna Therapeutics has announced today that it has entered into a collaboration with scientists from the Progreso y Salud Foundation (FPS) at Cabimer in Seville, to jointly examine the efficacy of Amarna’s SVec™ gene delivery vector for the development of effective immunotherapies for diabetes mellitus type 1 (DM1) and multiple sclerosis (MS).

READ MORE

First Data on Using a Therapeutic Form of ACE2 To Treat COVID-19 Published
Product News

A case report published today in The Lancet Respiratory Medicine outlines the first compassionate use of recombinant soluble human ACE2 (APN01) to treat a female 45-year-old patient who was diagnosed with severe COVID-19.

READ MORE

Solus Listeria monocytogenes ELISA Assay for Testing Across Food and Environmental Samples
Product News

PerkinElmer is a global leader committed to innovating for a healthier world. On September 21st, 2020 they launched the PerkinElmer Solus Listeria monocytogenes ELISA Assay. This new offering will help high throughput food processors and contract labs focus on L. mono testing for food and environmental surface samples.

READ MORE

 
Advertisement